Literature DB >> 21849679

Membrane-associated CD93 regulates leukocyte migration and C1q-hemolytic activity during murine peritonitis.

Mallary C Greenlee-Wacker1, Carlos Briseño, Manuel Galvan, Gabriela Moriel, Peter Velázquez, Suzanne S Bohlson.   

Abstract

CD93 is emerging as a novel regulator of inflammation; however, its molecular function is unknown. CD93 exists as a membrane-associated glycoprotein on the surface of cells involved in the inflammatory cascade, including endothelial and myeloid cells. A soluble form (sCD93) is detectable in blood and is elevated with inflammation. In this study, we demonstrate heightened susceptibility to thioglycollate-induced peritonitis in CD93(-/-) mice. CD93(-/-) mice showed a 1.6-1.8-fold increase in leukocyte infiltration during thioglycollate-induced peritonitis between 3 and 24 h that returned to wild type levels by 96 h. Impaired vascular integrity in CD93(-/-) mice during peritonitis was demonstrated using fluorescence multiphoton intravital microscopy; however, no differences in cytokine or chemokine levels were detected with Luminex Multiplex or ELISA analysis. C1q-hemolytic activity in CD93(-/-) mice was decreased by 22% at time zero and by 46% 3 h after thioglycollate injection, suggesting a defect in the classical complement pathway. Leukocyte recruitment and C1q-hemolytic activity was restored to wild type levels when CD93 was expressed on either hematopoietic cells or nonhematopoietic cells in bone marrow chimeric mice. However, elevated levels of sCD93 in inflammatory fluid were observed only when CD93 was expressed on nonhematopoietic cells. Because cell-associated CD93 was sufficient to restore a normal inflammatory response, these data suggest that cell-associated CD93, and not sCD93, regulates leukocyte recruitment and complement activation during murine peritonitis.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21849679      PMCID: PMC3169757          DOI: 10.4049/jimmunol.1100803

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  20 in total

1.  The lectin-like domain of thrombomodulin interferes with complement activation and protects against arthritis.

Authors:  M Van de Wouwer; S Plaisance; A De Vriese; E Waelkens; D Collen; J Persson; M R Daha; E M Conway
Journal:  J Thromb Haemost       Date:  2006-08       Impact factor: 5.824

2.  Plasma CD93 concentration is a potential novel biomarker for coronary artery disease.

Authors:  A Mälarstig; A Silveira; D Wågsäter; J Öhrvik; A Bäcklund; A Samnegård; M Khademi; M-L Hellenius; K Leander; T Olsson; M Uhlén; U de Faire; P Eriksson; A Hamsten
Journal:  J Intern Med       Date:  2011-03-21       Impact factor: 8.989

3.  CD45 regulates Src family member kinase activity associated with macrophage integrin-mediated adhesion.

Authors:  T Roach; S Slater; M Koval; L White; E D Cahir McFarland; M Okumura; M Thomas; E Brown
Journal:  Curr Biol       Date:  1997-06-01       Impact factor: 10.834

4.  CD93 is rapidly shed from the surface of human myeloid cells and the soluble form is detected in human plasma.

Authors:  Suzanne S Bohlson; Richard Silva; Maria I Fonseca; Andrea J Tenner
Journal:  J Immunol       Date:  2005-07-15       Impact factor: 5.422

5.  Purification and radiolabeling of human C1q.

Authors:  A J Tenner; P H Lesavre; N R Cooper
Journal:  J Immunol       Date:  1981-08       Impact factor: 5.422

6.  Particularities of the vasculature can promote the organ specificity of autoimmune attack.

Authors:  Bryce A Binstadt; Pratik R Patel; Herlen Alencar; Peter A Nigrovic; David M Lee; Umar Mahmood; Ralph Weissleder; Diane Mathis; Christophe Benoist
Journal:  Nat Immunol       Date:  2006-01-29       Impact factor: 25.606

7.  Murine CD93 (C1qRp) contributes to the removal of apoptotic cells in vivo but is not required for C1q-mediated enhancement of phagocytosis.

Authors:  Peter J Norsworthy; Liliane Fossati-Jimack; Josefina Cortes-Hernandez; Philip R Taylor; Anne E Bygrave; Richard D Thompson; Sussan Nourshargh; Mark J Walport; Marina Botto
Journal:  J Immunol       Date:  2004-03-15       Impact factor: 5.422

8.  The role of mast cells in thioglycollate-induced inflammation.

Authors:  R Qureshi; B A Jakschik
Journal:  J Immunol       Date:  1988-09-15       Impact factor: 5.422

Review 9.  Inflammation and cancer.

Authors:  Lisa M Coussens; Zena Werb
Journal:  Nature       Date:  2002 Dec 19-26       Impact factor: 49.962

10.  The lectin-like domain of thrombomodulin confers protection from neutrophil-mediated tissue damage by suppressing adhesion molecule expression via nuclear factor kappaB and mitogen-activated protein kinase pathways.

Authors:  Edward M Conway; Marlies Van de Wouwer; Saskia Pollefeyt; Kerstin Jurk; Hugo Van Aken; Astrid De Vriese; Jeffrey I Weitz; Hartmut Weiler; Peter W Hellings; Paul Schaeffer; Jean-Marc Herbert; Désiré Collen; Gregor Theilmeier
Journal:  J Exp Med       Date:  2002-09-02       Impact factor: 14.307

View more
  9 in total

1.  CD93 regulates central nervous system inflammation in two mouse models of autoimmune encephalomyelitis.

Authors:  Mark R Griffiths; Marina Botto; Bryan Paul Morgan; James W Neal; Philippe Gasque
Journal:  Immunology       Date:  2018-07-11       Impact factor: 7.397

2.  CD93 is Associated with Glioma-related Malignant Processes and Immunosuppressive Cell Infiltration as an Inspiring Biomarker of Survivance.

Authors:  Kaiming Ma; Suhua Chen; Xin Chen; Xiaofang Zhao; Jun Yang
Journal:  J Mol Neurosci       Date:  2022-08-25       Impact factor: 2.866

3.  CD93 gene polymorphism is associated with disseminated colorectal cancer.

Authors:  Renate S Olsen; Mikael Lindh; Emina Vorkapic; Roland E Andersson; Niklas Zar; Sture Löfgren; Jan Dimberg; Andreas Matussek; Dick Wågsäter
Journal:  Int J Colorectal Dis       Date:  2015-05-26       Impact factor: 2.571

4.  CD93 and GIPC expression and localization during central nervous system inflammation.

Authors:  Chun Liu; Zhichao Cui; Shengjie Wang; Dongmei Zhang
Journal:  Neural Regen Res       Date:  2014-11-15       Impact factor: 5.135

5.  Soluble CD93 in Serum as a Marker of Allergic Inflammation.

Authors:  Hye Jung Park; Heejae Han; Sang Chul Lee; Young Woong Son; Da Woon Sim; Kyung Hee Park; Yoon Hee Park; Kyoung Yong Jeong; Jung Won Park; Jae Hyun Lee
Journal:  Yonsei Med J       Date:  2017-05       Impact factor: 2.759

Review 6.  C-type lectin domain group 14 proteins in vascular biology, cancer and inflammation.

Authors:  Kabir A Khan; Jack L McMurray; Fiyaz Mohammed; Roy Bicknell
Journal:  FEBS J       Date:  2019-07-29       Impact factor: 5.542

7.  Soluble Complement Component 1q Receptor 1 (sCD93) Is Associated with Graft Function in Kidney Transplant Recipients.

Authors:  Małgorzata Kielar; Paulina Dumnicka; Ewa Ignacak; Alina Będkowska-Prokop; Agnieszka Gala-Błądzińska; Barbara Maziarz; Piotr Ceranowicz; Beata Kuśnierz-Cabala
Journal:  Biomolecules       Date:  2021-11-02

8.  CD93 Correlates With Immune Infiltration and Impacts Patient Immunotherapy Efficacy: A Pan-Cancer Analysis.

Authors:  Zerui Zhang; Mengli Zheng; Qiang Ding; Mei Liu
Journal:  Front Cell Dev Biol       Date:  2022-02-15

9.  Soluble CD93 as a Novel Biomarker in Asthma Exacerbation.

Authors:  Naseh Sigari; Ali Jalili; Laili Mahdawi; Ebrahim Ghaderi; Mohammadi Shilan
Journal:  Allergy Asthma Immunol Res       Date:  2016-09       Impact factor: 5.764

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.